Gabriel Vorobiof

Assistant Professor of Diagnostic Radiology and Medicine
Section of Cardiovascular Medicine

Clinical Interests

Nuclear cardiology, Cardiac MRI, Cardiac CT, Ischemic heart disease, Cardiomyopathies, Valvular disease

Selected Publications

• Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, Siu S, Brown KA. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118(10):1011-20.
• Rybicki FJ, Otero HJ, Steigner ML, Vorobiof G, Nallamshetty L, Mitsouras D, Ersoy H, Mather RT, Judy PF, Cai T, Coyner K, Schultz K, Whitmore AG, Di Carli MF. Initial evaluation of coronary images from 320-detector row computed tomography. The International Journal of Cardiovascular Imaging. 2008;24(5):535-46.
• Vorobiof G, Goldenberg I, Moss AJ, Zareba W, McNitt S. Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). Am J Cardiol. 2006;98 (10):1383-6.
• Vorobiof G, Blaxall BC, Bisognano JD. The future of endothelin-receptor antagonism as treatment for systemic hypertension. Curr Hypertens Rep. 2006;8(1):35-44.
• Vorobiof G, Kroening D, Hall B, Brugada R, Huang D. Brugada Syndrome with Marked Conduction Disease -Dual Implications of a Novel SCN5A Mutation. Pacing & Clinical Electrophysiology. 2008;31(5):630-4.

Education:	MBBCh, University of the Witwatersrand, Johannesburg, South Africa, 1997
Training:	Residency: St. Luke’s Roosevelt Hospital Center, Columbia University College of P & S, 2004 Cardiology Fellowship: University of Rochester, 2007 Advanced Cardiac Imaging Fellowship: Brigham & Women’s Hospital, Harvard Medical School, 2008

Contact

Campus Address
Yale University School of Medicine
Department of Internal Medicine
Section of Cardiovascular Medicine
333 Cedar St, MRC 147
New Haven, CT 06520

E-mail
gabriel.vorobiof@yale.edu

Telephone
203.785.5913

Fax
203.785.3061